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Introduction
When one considers the stresses to which we
subject the weight-bearing joints of our body over
the course of a lifetime,

one begins to appreciate

the remarkable dependability and durability of that
very thin layer of articular cartilage which covers
the surfaces of those joints.

Imposed on these sur¬

faces are variety of constant and cyclic loads,

stem¬

ming from forces which are both compressive and shear¬
ing.

Yet,

this thin layer stands up to year after

year of load-bearing,

with its own system of lubrica¬

tion and replenishment of worn meterial,

an achievement

which cannot be boasted by any man-made mechanical
device.
Unfortunately,

nature Itself is not free

from imperfections and this wondrous mechanical system
often fails.

A small mechanical breakdown,

a slight

biochemical change often leads to a chain of events
which results in pain and incapacitation.

It is esti¬

mated that some 40 million Americans manifest radio¬
logical evidence of such joint degeneration,
some

including

85# of all those over 70 years of age and at a

cost of

$13 billion in 1976.
This paper will briefly discuss some of the

pertinent properties of articular cartilage and degen¬
erative joint disease

(osteoarthritis).

It will then

2

turn to some of the current ideas concerning the bio¬
chemical processes which may be responsible for joint
failure and some of the experiments performed here to
help elucidate one of these ideasi

that the joint

disease is mediated through the production of prosta¬
glandins within the joint.

3Articular Cartilage
Development
Joint development begins during the fifth
to sixth week of embryonic life with the appearance of
limb buds

(Langman 1975) •

appear in the appendages,

Soon thereafter,
forming joints.

clefts
At birth,

endochondral bone formation occurs at the epiphyses.
The articular cartilage may be considered as a partial
spherical shell which covers the cartilage surrounding
the ossification center.

This superficial shell has

a separate population of chondrocytes which lay down the
articular cartilage.

It ceases to proliferate at about

the first year of life (Mankin 1963).
Upon skeletal maturity and the appearance
of the tidemark (seen on hematoxylin-eosin staining),
no further mitosis occurs
However,

(mankln 1963,

under appropriate stimulation,

Crelin 1957)*
the chondro¬

cytes can revert to a chondroblastic form with DNA
production,
production.
man 1975).
i960),

mitosis and increased mucopolysaccharide
These stimuli may be growth hormone

sustained compression (Crelin & Southwlck

laceration (Meachim 1963) and osteoarthritic

destruction (McDevitt 1973)*
case,

(Chris-

Unfortunately,

in the last

the new proteoglycans are either not produced

in sufficient quantities or are of poorer quality
(McDevitt 1973) and destruction is not completely rev¬
ersed.

Biochemistry
Besides the chondrocytes,

articular cartilage

consists mostly of matrix made up of 3 principal compo¬
nents!

water,

collagen and proteoglycans.
Seventy five to 85$ of the weight of

Wateri

articular cartilage is comprised of water (Mankin &
Thrasher 1975)*

Of this,

about

is mechanically

trapped in a complex gel of collagen and proteoglycan
and is freely exchangeable with both the synovial fluid
and systemic circulation (Jaffe,
Collagen

1

et al 197*+) •

Collagen fibrils are aggregates

of tropocollagen molecules.

Tropocullagen is usually

a triple helix with 2 identical <x-j_ chains and a some¬
what differentcx2 chain (Muir 1873)*

For example,

skin collagen is a mixture of molecules of compositions
(5*1 (1)] 2<*2 and

[9^1 (111

3 (McDevltt 1973)*

Articular

cartilage tropocollagen consists of 3 identical strands
of 04(11) chains,

which has properties very similar to

the 0(^(1) chain from skin (Strawich & Minimi 1971)*

It

should be noted that articular cartilage collagen is
almost completely resistant to extraction by reagents
commonly used for extraction of skin cartilage,
5 M guanidine-HCl

(Miller,

et al 1969),

6 M urea (Strawich & Nimmi 1971)•

such

2 M MgCl2 or

This has been attri¬

buted to both intra- and inter-molecular cross-linking
and ionic interactions between the positively charged
proteoglycans

(McDevltt 1973)*

5
The biocynthesis of collagen Is now wellunderstood though the work has been done mostly with
chick embryo cartilage (Muir 1973)*

The polypeptide

chains are formed singly which then spontaneously ag¬
gregate to form a triple helix, at which stage, the
molecule is referred to as protocollagen.

Hydroxylation

of some of the proline and lysine residues then occurs
(Rosenbloom & Prockop 1969)*

A different enzyme is

involved in the hydroxylation of each (Weinstein, et al
1969)*

Some of the hydroxylated lysine residues are

then glycoslated to either glycosyl-galactosyl-hydroxylysine or galactosyl-hydroxylysine (31umenkrantz,

et al

1969)» before the tropocollagen molecule is secreted
from the cell. In the cartilage matrix, the molecules
aggregate to form fibrils, after which a slow maturational process of intra- and intermolecular crosslinking occurs (Muir 1973)*
There is a slow, but detectable level of coll¬
agen turnover in adult rabbit articular cartilage which
increases with experimentally-induced osteoarthritis
(Repo & Mitchell 1971)•
Proteoglycans 1

Proteoglycans are large mole¬

cules which structurally consist of a protein core from
which are hung glycosaminoglycan side chains, made of
3 major disaccharides 1 chondroitln-4-sulphate, chondroitin'
6-sulphate and keratan sulfate, the structures of which
are shown in Figure 1.

Chondroitih-4-sulfate has a

OH

Figure It

H

NHAc

Disaccharide repeating units of
4-sulphate,

(a) chondroitin

(b) chondroitin 6-sulphate and

(c) keratan sulphate.

(From Freeman M.A.R. 1974)

6

disaccharide unit consisting of glucuronic acid linked
to N-acetyl galactosamine,

with the sulphate group at

the galactose C4 position.

In the case of chondroitin-

6-sulphate, the sulphate is in the C6 position.
keratan sulphate,

In

there is a galactose molecule linked

to an N-acetyl glueosamine-6-sulphate molecule.
chondroitin sulphate chains tend to be linear,
to 60 disaccharide units,
may be more variable,

Moreover,

with 30

while that of keratan sulphate

with 15 to 30 disaccharide units

per chain with some branch points
1974).

The

(Hopwocd & Robinson

keratan sulphate also contains small

amounts of other sugars such as fucose,
tosamine and mannose

sialate,

galac¬

(Mathews & Cifonelli 1965)*

The

chondroitin sulphate chains do not appear to be distri¬
buted uniformly along the protein core but are present
in pairs

(Mathews 1971),

with about 10 amino acid resi¬

dues between individual chains and about 35 residues
between pairs.

It is believed that the protein core

helps to protect the polysaccharides from enzymatic
attack by holding them closely together (Muir 1973)*
This is consistent with the observation that proteo¬
glycans are more susceptible to attack by proteolytic
ensymes than hyaluronidases

(Cessi & Bernardi 1965) •

The relative proportions of the glycosaminoglycans change
over life.
increases,

The concentration of keratan sulphate
that of chondroltin-4-sulphate falls and

that of chondroitin-6-sulphate remains constant

(Barnett,

7
et al 1963) •
The proteoglycan monomer appears as a comb
with the protein core acting as the "backbone" and the
polysaccharide "teeth" hanging from it.

Rosenberg has

postulated that the C terminals of the polypeptides
associate to form a dimer.

Dimers then aggregate around

a link protein to form starlike first-order aggregates.
The free N terminals of some of the "arms" of the stars
can further associate with link proteins of other firstorder aggregates to form second order aggregates
ters of stars)

(Rosenberg,

et al 1970),

although it is

unclear that this actually occurs in vivo.
to the link protein,

(clus¬

In addition

hyaluronic acid is necessary for

aggregation* and the present evidence suggests that it
interacts directly with one part of the link protein
(Hardingham & Muir 1972,

1973» Kuettner,

et al 1975) •

Several "stars" are believed to be strung out along a
long strand of hyaluronic acid.

This extended structure

stems from the mutually repulsive forces of the negativelycharged polysaccharide side-chains,

resulting in their

occupation of the greatest amount of space.

This elec¬

trostatic interaction by itself contributes to cartilage
elasticity.

This structure also allows it to retain

large quantities of water,

and gives it the ability to

absorb stresses placed on the cartilage by increasing
the viscosity of the cartilage matrix (McDevitt 1973)*
This shock-absorbing quality is unique to cartilage.

.

8

The proteoglycans are synthesized by the chon¬
drocytes.

The polypeptide chain Is made on the ribosomes.

The disaccharides are formed separately and are then
polymerized at the appropriate linkage sites on the poly¬
peptide

(Horwitz

2c

Dorfman 1968) .

Sulphation occurs

both in the rough endoplasmic reticulum and Golgi appa¬
ratus

(Martinez,

packaged,

et al 1977)*

The molecules are then

also in the Golgi apparatur,

and released.

Some form of feedback regulation appears to
be in operation.

Chondrocytes have been shown both in

vitro (Bosmann 1968)

and in vivo

(Edwards & Michael 1977)

to respond to depletion of proteoglycan by increasing
production.
Proteoglycans are degraded by both lysosomal
and non-sysosomal enzymes present in the cartilage
(Chrisman
Maroudas

2c

Fessel 1962,

(1975)

cartilage.

All 1964).

Using -^S-SO^,

was able to measure the half life of

She found that the Ti. of the femoral head

cartilage was 800 days while that of the femoral cond¬
yle cartilage was J00 days.

She also found that diff¬

erences occurred between different depths of the carti¬
lage.

Hall,

et al

(1977)•

on the other hand,

found that

although most of the proteoglycan in rabbits had a life¬
span of 600 days,
days,

9•5% of it had a half life of only 6.8

implying an active and inactive pool of proteo¬

glycans.

Turnover of the glycosaminoglycans occurs at

different rates, with keratan sulphate being turned over

9

faster than the chondroitln sulphates.
There is variation in the concentration of
glycosarainoglycans both depending on the depth (Lipshitz,
et al 1976) and the topographical location (Bjelle 197*0 •
An increase in concentration with depth occurs,
about 2>5% of the
decline

cartilage depth,

(Lipshitz,

et al 197^)*

up to

followed by a gradual
Bjelle

(197*+)

showed

significant differences in the hexosamine concentrations
in different
joint.

locations of the femoral side of the knee

There is also considerable variation from one

person to the next

(Maroudas 1975)*

The negative charges of the sulphate and carboxylate groups combine with many dyes which allow the
hexosamines to be identified histochemically.
for example,

Safranin-O,

can be used to detect the glycosaminogly¬

cans semi-quantitatively (Rosenberg 1971)*
per conditions,

Under pro¬

the dye binds stoichiometrically to the

negatively charged groups.

There is no interference from

the collagen.

Architecture
Classically, using techniques of light micro¬
scopy,

the architecture,of articular cartilage consists

of the following zones proceeding from superficial to
deep*

the gliding zone,

the transitional zone,

zone,

the tidemark and the calcified zone,

over the subchondral bone.

the radial

which lies

Recent ultrastructural work

.

10
has increased our knowledge of the histology but the
names of the basic zones may be largely retained.
a.
layers:

The gliding zone:

This is subdivided into two

the superficial and tangential layers.

The super¬

ficial layer is about 200 microns thick and consists only
of fine collagen fibrils arranged randomly
There is no proteoglycan in this layer.
tial layer,

(Redler 1974).

In the tangen¬

collagen fibers are arranged in a plane para¬

llel to that of joint motion (Redler 1974).

Cells in

this layer resemble fibroblasts with their long axes
in a tangential plane.

It has been found that the su¬

perficial layers have a higher tensile strength to forces
parallel rather than perpendicular,
joint motion (Woo,

et al 1976),

to the direction of

a finding consistent

with the ultrastructural observations.

This combination

of fine fibrils with underlying fibers is seen by the
scanning electron microscope as a series of gently undu¬
lating ridges and furrows

(Redler 1974).

It is proposed

that this topographical arrangement serves as a means of
facilitating joint lubrication by allowing collection
of synovial fluid (Chrlsman 1978) .

The tangential

orientation of the collagen fibers is also ideal for
resisting destruction due to the shearing forces of joint
articulation.
b.

The transitional zone:

The ratio of cells to

matrix decreases as the depth increases.
cytes tend to be in spherical lacunae,

The chondro¬

separated by matrix

containing water, collagen and proteoglycan.

Some of

the collagen bundles are no longer tangential but are
oblique.
c.

The radial zone:

Deep to the transitional

zone, a zone of more radially oriented collagen fibers
are encountered.

The chondrocytes are seen under the

light microscope to be lined up in columns.

Some of

the radial bundles form arcade-like patterns (Hunter &
Finley 1973) although the arches are not formed by con¬
tinuous fibers.

Deep in the zone, the bundles tend to

anastomose into large bundles and merge into the calci¬
fied zone (Redler, et al 1975)*

The radial arrangement

provides the cartilage with strength against compressional
stresses, as in joint load-bearing.

This zone is also

particularly rich in proteoglycans and water, which
gives it the elasticity and added stiffness (Meachim &
Stockwell 1973) •
d.

The tidemark:

This is an undulating, hemat¬

oxylin-staining line of 2 to 5 microns in thickness,
which demarcates the calcified and uncalcified portions
of articular cartilage.

There are 3 bands discernible:

(1) a band of randomly-oriented fibrils continuous with
those of each side of the tidemark,

(2) a band of fibrils

larallel to the surface of the calcified cartilage and
(3) a band of fibrils oriented perpendicular to that
surface.

It has been suggested that this arrangement

serves as a tethering mechanism for the flexible radial

12
fibers of the radial zone and prevents them from being
sheared off by tangential stresses at their points of
anchorage to calcified cartilage
e.

The calcified zone:

(Eedler,

et al 1975)*

Calfification of this zone

increases with skeletal maturity.

In Immature cartilage,

there are short columns of chondrocytes separated by
matrix.

Vascular structures are present,

with calci¬

fication most advanced In the perivascular areas.

Cal¬

cification continues to progress upon skeletal maturity,
with loss of the columnar organization of the chondro¬
cytes.

The function of the calcified zone is to provide

the non-calcifled cartilage with a firm attachment to
the sub-chondral bone

(Meachim & Stockwell 1973).

with

which it has a markedly undulating interface.
f.

The subchondral bone 8

articular cartilage per se.

This is not part of the

There is an endplate con¬

sisting of dense cortical bone which supports the carti¬
lage.

In turn it is supported by trabecular bone.

It

is believed that the trabeculae have shock-absorptive
properties.

-
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Osteoarthritis
OstoarthrltIs
hypertrophic arthritis)

(degenerative joint disease,
is a condition which afflicts

a large segment of the older population.
ple,

In young peo¬

osteoarthritis may occur as a result of trauma,

septic arthritis or congenital abnormalities of either
a biochemical or morphological nature

(secondary form).

The exact etiology and pathogenesis of osteoarthritis,
especially that which afflicts the older age group
(primary form),
However,
later.

have not been completely worked out.

some of the current ideas will be discussed
There is at present no cure for it.

Treatment

is directed towards minimizing symptoms and incapacit¬
ation.

Clinical Manifestations
The most important complaint of patients with
this condition is joint,pain,
weight bearing.

There is also stiffness,

rheumatoid arthritis,
stiffness,

but unlike

the pattern of prolonged morning

gradually subsiding,

physical examination,
motion,

especially with motion and

is usually absent.

On

there is often decreased range of

tenderness to palpation with perhaps a small

effusion,

some bone enlargement and crepitus.

Markedly

warm and erythematous joints are unusual. (Mannik &
Gilliland 1977) •
When the distal lnterphalangeal joints of the

14
fingers are Involved,
distal phalanges

bony nodules at the base of the

(Heberden's nodes) are found,

the cor¬

responding lesions of the proximal lnterphalangeal joints
are called Bouchard's nodes.

Wrists,

elbows and shoulders

are uncommonly affected.
Osteoarthritis of the spine usually causes
back pain and stiffness.

Radiologically,

osteophytes

are readily seen although most cases are asymptomatic.
They may encroach upon the spinal foramina and cause
nerve root compression giving rise to radicular pain,
weakness of affected muscle groups and even muscle
atrophy.

In the cervical area,

they may occlude the

vertebral artery on turning the head,

giving rise to

transient visual disturbances or syncope.
Hip involvement is one of the most disabling.
With severe Involvement,

patients may be completely un¬

able to ambulate on their own.
pain in the hips,

Patients complain of

groin or knees.

is often loss of joint space

Radiologically,

there

(indicating articular car¬

tilage destruction) and bony thickening of the femoral
heads.

Secondary osteoarthritis of the hip usually

occurs at an earlier age.
fractures,

The causes include trauma,

septic arthritis,

rheumatoid arthritis,

congenital abnormalities of the hip (dislocation,
plasia),

any
dys¬

slipped capital femoral epiphysis and avascu¬

lar necrosis

(often associated with sickle cell disease,

steroid therapy,

etc.).

15Trauma is usually the cause of osteoarthritis
of the knee.

Injuries to the menisci or supporting

ligaments give rise to joint instability and abnormal
wear and tear of the articular cartilage.

Pain on weight¬

bearing and ambulation is the most common complaint.
Similarly,

involvement of the ankles in osteo¬

arthritis is often associated with trauma.

Primary os¬

teoarthritis of the ankles is uncommon.
It is of note that polyarticular osteoarthritis
is a manifestation of acromegaly.

There is a thicken¬

ing of the synovial membranes and articular cartilage.
As mentioned before

(Chrisman 1975)•

growth hormone can

cause mitosis and DNA production in "dormant" chondro¬
cytes .

Diagnosis
The diagnosis is suggested by the age,

symptoms,

pattern of joint involvement and lack of accompanying
abnormalities.
There is usually no elevation of the erythro¬
cyte sedimentation rate.

The joint fluid is often slight¬

ly turbid and may have a small amount of fibrin clot.

The

white cell count should be less than 2000 per mm^ with
less than 25% polymorphonuclear cells.

Higher white cell

counts suggest the presence of the more inflammatory arthritldes (rheumatoid,

septic,

etc.).

Radiological examination of the joints is very

.
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useful for determining the extent of disease and for
following its progress.
lipping,

Narrowing of the joint spaces,

osteophytes are all consistent with but not

diagnostic of osteoarthritis.

Treatment
Treatment of osteoarthritis is aimed at the
relief of pain and the minimization of disability. Gen¬
eral measures include a weight reduction program for
over-weight individuals and a program of moderate exer¬
cise.

A decrease in load-bearing on large joints helps

decrease symptoms although no significant correlation
between obesity and osteoarthritis has been found (Saville and Dickson 1968) .

The exercise program is aimed

toward maintenance of joint mobility but heavy exercise
should be avoided as further trauma can occur.
patient should be kept reassured that,
of cases,
(Howell,

The

in the majority

osteoarthritis is neither fatal nor crippling
et al 1968) .
The mainstay of drug therapy is aspirin at

a dose of 2 to 4 gm. a day,

if tolerated by the patient.

For those who do not tolerate aspirin well,

other po¬

tent anti-inflammatory and analgesic agents are avail¬
able but they have their own problems of adverse effects.
Indomethacln (75 to 100 mg. a day)

is very effective in

many patients as is phenylbutazone (200 to 400 mg. a
day) but the latter drug should be used only for short

.
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periods (1 week) due to its toxicity and should be reserv
ed for treatment of acute exacerbations of symptoms.
Among those patients who do not respond well
to medical management, a portion will benefit from sur¬
gical procedures which include osteotomies, arthroplas¬
ties and joint replacements.

The hip joint has enjoyed

the best results in total replacement, using a variety
of prostheses, the most popular ones being those of
Charnley (1961) and McKee and Farrar (McKee & WatsonFarrar 1966).

Follow-up studies have been very impress¬

ive, with good to excellent success rates of these two
methods being greater than 90% on follow-ups of up to
10 years (Charnley & Cupic 1973. McKee & Chen 1973)*
This has been considered a major advancement in the man¬
agement of osteoarthritis of the hip and has spared many
patients from pain and disability.

Pathology
The earliest pathological changes are chond¬
romalacia (loss of proteoglycan from articular cartilage)
and fissuring.

The articular surface becomes slightly

irregular (Robbins 197^)•

With progression of chondro¬

malacia, there is an increase in the number of chond¬
rocytes which are distributed in clusters (’'cloning")
(Mankin & Llppielo 1970).

In addition, deep clefts or

fissures form in the cartilage.

The above processes are

denoted by the term "fibrillation", which is considered

.
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to be the hallmark of degenerative change In osteo¬
arthritis

(Collins 1949).

Correlating this with the

present ultrastructural data,

one can conclude that as

the superficial tangential layers lose proteoglycan,
the layers are destroyed and are denuded.

The underlying

radial fibers are then exposed to the joint stresses
and are in turn damaged along their lines of weakness,
giving rise to histological fissuring.

Eventually,

continued wear and tear of the unprotected cartilage
leads to massive denudation,

which shows up radiolo-

glcally as narrowing of the joint space.
The exposed underlying bone becomes thicken¬
ed with new bone formation.
region,

In the marrow of the same

small islands of cartilage of sometimes fibrous

tissue (pseudocysts),

are observed,

either "driven in" or formed de novo
Some cartilage,

which may have been
(Robbins 1974).

especially that around the margins,

ossify and project above the surface to form the charac¬
teristic spurs or osteophytes.

The denuded surface

of the bone itself becomes dense,
(eburnatlon)

(Mannik

Sc

smooth and glistening

Gilliland 1976).

There is some thickening and inflammatory
edema of the synovia,

but this is low grade and does not

have the vascularization or leukocytic infiltration
found in the more highly inflammatory arthritides
(Robbins 1974).
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Pathogenesis
What causes the osteoarthritic changes?

This

question is more easily answered for the secondary
forms than for the primary form.
It has long been held that osteoarthritis
occurs as a consequence of trauma which results in some
alteration of the joint anatomy.

In recent years,

with

our greater awareness of the biochemical make-up of
tissues,

the definition of trauma was naturally broad¬

ened to cover any events which cause some microstructural or biochemical changes

in the joint.

Much work

has been done in the Induction of osteoarthritis by
applying stresses to the joints under laboratory cond¬
itions .
The role played by mechanical trauma is
obvious and well-documented.

Among the many studies

available is that Lane,

(1978) who performed

et al

medial meniscectomies and transections of the medial
collateral and both cruciate ligaments of rabbit knees.
It was found that,

although it took 2 months for gross

histological changes to occur,

it took only 1 day for

detectable changes in the mechanical properties to take
place.

Presumably,

osteoarthritis develops as a result

of abnormal contact pressures.

In osteoarthritis as¬

sociated with burnt out rheumatoid arthritis,

synovial

and periarticular tissues proliferate and invade the
articular cartilage

(Mills 1970).

The inflammatory

.
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reaction resulting from a septic

joint will induce the

same changes.
The intra-articular presence of crystals in
gout,

pseudogout and ochronosis

(Laskar & Sargison 1970)

gives rise to abrasion of the articular surface and in
addition can trigger off a foreign body reaction in the
synovium (Sokoloff 1972).
Structural abnormalities secondary to condi¬
tions such as the dysplasias,

Perthe's disease,

fracture,

dislocation and infarction fall into the broad category
of mechanical trauma secondary to joint deformation.
In short,

any event or condition which alters

the make-up of the joint,
or biochemical,

be it anatomical,

will predispose that

cellular

joint to develop

osteoarthrltlc changes.
What about the more common primary or "idio¬
pathic" form?

Here,

very little is known about the

inciting or etiological event.
not universally,

It is widely,

though

believed that the first changes occur

in the articular cartilage.

There are those who pro¬

pose that vascular changes in the underlying bone are
the Initial events
Helal 1968,

(Arnold!,

e£ al 1972,

Hulth & Hernborg 1968).

Brookes &

Others propose that

the initial event is the loss of resilience in the
underlying bony trabeculae

(Radin & Paul 1970).

With¬

out going into the controversies surrounding the diff¬
erent hypotheses,

it is sufficient to say that most

21
workers a?ree that the Initial events affect the arti¬
cular cartilage

(fibrillation).

This begs the question

regarding what leads to fibrillation.

Putting together

the fact that osteoarthritis tends to occur in old
people and that any form of trauma can give rise to
osteoarthritis,

it is attractive to postulate that the

inciting event in primary osteoarthritis is the damage
accumulated from small doses of minor trauma during
long-standing,

normal use.

hypothesis is difficult,

Although attractive,

if not impossible,

this

to prove,

since there are no good laboratory or epidemiological
models for "normal use".
One question has been whether osteoarthritlc
change represents an accelaration of normal ageing in
articular cartilage.

Comparison of autopsy material

has shown that fibrillation can be found in the joints
of unselected subjects

(Meachim 1972),

in osteoarthritic patients,
stage.

On the other hand,

similar to that

but of a less advanced
3yers,

et al

(1970)

looked

at the location of these lesions and found significant
differences between osteoarthritic and unselected cases.
As noted earlier,
teoglycans changes with age.
event?

Again,

the composition of the pro¬
Could this be the Initial

there is no data available.

In summary,
arthritis is unknown.

the etiology of primary osteo¬
The notion of long-standing,

normal use as being the cause is attractive but difficult

.
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to prove scientifically.
Whatever the etiological factors are,
result is the same.

the end

There is a loss of proteoglycans

accompanied by a deterioration of the mechanical pro¬
perties of the cartilage

1973)*

(Lane,

et_ al 1978.

McDevitt

As the process of fibrillation advances,

ul¬

ceration and erosion can be seen histologically.
How does this loss of proteoglycan take place?
The presence of various species of degradative enzymes
have been demonstrated in the synovial fluid (Lack &

Ali 1967» Sapolsky, et_ aJL 1973# 197^. Ehrlich, et_ al
1975)» the best known of which were the cathepsins,
also found in rheumatoid synovia.

However, it was later

discovered that purified cathepsins have little proteo¬
lytic activity as the pH increases to 7 and that the
significant tail-end of its activity at that pH was
actually due to a contaminant in the previous cathepsin
preparations (Woessner 1973. 1973a).

By using known

inhibitors of the cathepsins and various other enzymes
of the synovia and leukocytes, Howell demonstrated that,
at the pH of synovial fluid, proteolytic activity re¬
sided in a neutral protease derived from the chondro¬
cytes (Howell 1975)*
chloroquine.

This protease was inhibited by

Teitz and Chrisman ( 1975) found that

chloroquine inhibited the prostaglandin-induced destruc¬
tion of rabbit articular cartilage.

These authors felt

that the action of chloroquine might be to inhibit the
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synthesis of proteases.

In light of the findings of

other workers

et al 197*0.

(Sapolsky,

the action may

be direct inhibition of the neutral protease.

This

distinction between the cathepsins and the neutral
proteases may be regarded as merely a semantic one.
The actions of the enzymes are similar,
their activities at different pH ranges.

they merely have
Therefore the

cathepsins can be regarded as acid proteases and con¬
versely,

the neutral protease can be regarded as a

neutral or basic cathepsin.
With the identity of the protease established,
we need to ask why it is present.
answer to that question.

There is no clear

It has been proposed that the

protease forms part of a system of continuous turnover
of cartilage proteoglycan (Howell 1975)*
by George & Chrisman (1968),

As sugested

joint motion may give rise

to matrix and cellular debris abraded from the surfaces
and some mechanism is needed for removing it.

The ac¬

tion of the protease could easily fit into such a scheme.
Osteoarthritis may then represent a process where,
some,

reason,

the protease becomes overactive,

for

or that

the proteoglycan-synthesizing capabilities of the chond¬
rocytes become underactive,

or some combination of both

of the above.
We now need to consider what factors trigger
off the proteolytic action mentioned above.

Much work

has been done in this area and the leading candidates
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seem to be either the cyclic nucleotides or the prosta¬
glandins.

As will be discussed below,

these 2 classes

of compounds interact very closely and may turn out to
be different components mediating the same sequence of
events.
It is well-known that cholera endotoxin stim¬
ulates the production of cyclic adenosine monophosphate
(cAMF).

Prostaglandins also seem to have this property.

Application of either cholera endotoxin or prostaglandin
(PGE^) to ileal mucosa causes inhibition of sodium
absorption and stimulation of chloride secretion (Greenough,

et, al 1969.

Al-Awqati,

et al 1970).

Using the _in vitro system to be described
below, Fulkerson,

et al

(1978)

showed that cholera en¬

dotoxin caused loss of proteoglycan from dog articular
cartilage.
et al

(1977)

In an analogous in vivo experiment, Floman,
injected cell-free extracts of streptococci

into rat knee joints and found a 3-fold rise in cathepsin D in the synovium.

It has been suggested that en¬

dotoxins stimulate CAMP via a prostaglandin Intermediate
(Bennett 1971. Jacoby

8c

Marshall 1972, Floman,

1977.

Herman

ments

(Jacoby & Marshall 1972, Floman,

8c

Moncada 1975)*

Herman & Moncada 1975).
be measured,

et al

In some of these experi¬
et al 1977,

a rise in prostaglandins could

which could be prevented by addition of

prostaglandin synthetase inhibitors such as lndomethacin.
This inhibition was accompanied by an inhibition of the
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effects of endotoxins.
It should be noted,

however,

that this effect

has not been universally demonstrated.

Prostaglandin

synthetase inhibitors failed to prevent endotoxininduced lipolysls in Isolated fat cells
1973)
1973)*

(Cuatrecasas

or cAMP accumulation in human leukocytes

(Bourne

It is possible that endotoxins can directly

stimulate cAMP production without going through pros¬
taglandins .
A further complication is added by the work
of Kuehl (197*** Kuehl,
in some systems,
taglandins.

et al 197*0*

who showed, that,

there exists a post-cAMP pool of pros¬

This pool would be intra-cellular and would

not be expected to respond to the action of prostaglan¬
din synthetase inhibitors.

Thus,

he proposed a more

complex modulating role of the prostaglandins rather
than a straightforward stimulating role.
Despite the controversies surrounding the
inter-relationship between the prostaglandins and cAMP,
we may propose a tentative model for the pathogenesis
of osteoarthritis

(Figure 2).

Any form of trauma

results in some alteration of physical forces in the
joint which,

by some yet unknown mechanism,

increase in prostaglandins in the joint.
of the primary form of osteoarthritis,
sequence is assumed to begin here.

causes an

In the case

the pathogenetic

The prostaglandins

then stimulate cAMP, cause a release of proteases,
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which then degrade cartilage proteoglycans and give
rise to the typical histologic picture of osteoar¬
thritis

Trauma
(mechanical, chemical,
Infectious, etc.)

Macroscopic or microscopic
alteration of joint anatomy.

Altered physical forces

Idiopathic

Endotoxin
(laboratory)

■*»

1

?

Prostaglandin
production.

I

Cyclic AMP
stimulated.

i
Proteases activated.

I

Loss of proteoglycans

i

Osteoarthritis.

Fig. 2:

A model for the pathogenesis of osteoarthritis.

.
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Purpose
Previous work performed in this laboratory
has demonstrated that prostaglandins can induce damage
to rabbit knees,
(Teitz

&

as shown by histological examination

Chrlsman 1975)*

Since then,

an _in vitro

system has been developed in this laboratory whereby
the actual loss of proteoglycan from the articular
cartilage can be biochemically determined.
Briefly,
is as follows:

the overall experimental method

Fresh articular cartilage is excised

from dogs* knees and placed in a series of solutions
containing the appropriate agents to be tested (pros¬
taglandins,

endotoxin,

etc.).

The cartilage slices

are then recovered and the concentration of proteogly¬
cans remaining are assayed by the method of Rondle and
Morgan (1955)*

By this method,

the cartilage is hydro¬

lyzed with concentrated hydrochloric acid.
down the proteoglycan into hexosamines,

This breaks

the concentra¬

tion of which can be determined spectrophotometrically.
Using this method,

the prostaglandin-induced

degradation of articular cartilage and the protective
action of chloroquine has been demonstrated
et al 1978).

In addition,

(Fulkerson,

the system has also been

employed to show the degradation of articular cartilage
by cholera endotoxin (Fulkerson,

et al 1978a).

The present study aims at demonstrating the
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effects of arachidonic acid on articular cartilage.
It has been shown that chondrocytes

in cell culture

are able to synthesize prostaglandins from arachidonic
acid (Lippiello,

et al 1977).

If this is so,

then

introduction of arachidonic acid into the incubation
medium of the cartilage slices should result in pros¬
taglandin production and cartilage degradation.

This

would provide an in vitro mbdel for part of the patho¬
genesis of osteoarthritis.
Furthermore,

this would provide a useful

system for the evaluation of the potency of prostaglan¬
din synthetase inhibitors.

Many such agents are used

in the treatment of osteoarthritis.
(Figure 3)

Indomethacin

is one of them and its clinical and pharma¬

cological properties have been well described (Woodbury
& Fingl 1975) •
Sulindac is a new non-steroidal anti-inflam¬
matory agent which has recently been released by the
Food and Drug Admlnistration for the treatment of ar¬
thritis.

It is a congener of indomethacin and is claimed

to have fewer side effects
Lancet 1977)*

(BianchiPorro,

It has been speculated that the reason

for the lower incidence of side-effects
trointestinal)
(Duggan,

et. al 1977»

(mostly gas¬

is related to its unique metabolism

et al 1977)•

Sulindac,

which is a sulfoxide,

is metabolized by the liver to the sulfone and sulfide
derivatives

(Figure 4).

The sulfone is readily excreted

0
COOH

Figure 3*

The chemical structure of indomethacin.

COOH

(sulfide)

Figure 4i

sulindac
(sulfoxide)

(sulfone)

The chemical structures of sulindac and its
sulfide and sulfone metabolites.
(From Duggan,

et al 1977)
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in the urine and has no pharmacological actions.
sulfide is not excreted in the urine

The

(Shen 1976).

is many times more active than sulindac

It

itself in its

anti-inflammatory action in several in vivo models of
inflammation (Duggan,

et al 1977)*

Thus,

it can be

considered a "pro drug" with little action until meta¬
bolized by the liver and this may help explain the lower
incidence of gastrointestinal side effects.
In the present work,

the ability of the

chondrocytes to synthesize prostaglandins from arachidonic acid will be shown by incubating cartilage slices
in medium containing arachidonic acid and observing the
loss of hexosamine from the cartilage.

In addition,

indomethacin and sulindac will be used to show that
inhibition of prostaglandin synthesis will result

in

protection of the cartilage against hexosamine loss.
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Methods
Preparation of solutions
1.

Incubation solutions!

prepared immediately before use.

Solutions were

Indoraethacin* and the

sulfide metabolite of sulindac** were dissolved in
sterile lactated Ringer’s solution in appropriate con¬
centrations.

Arachidonic acid*** was dissolved in

absolute ethanol.

Various quantities of each reagent

and solvent were transferred into sterile 50*®1» Erlenmayer flasks stoppered with cotton wool plugs,

such

that the total volume of solution was always 6 ml.
2.
acetylacetone

Alkaline acetylacetonet
(Fisher Scientific Co.)

in 0.5 N Na2C0^ to make 50 ml.

Two ml.

of

were dissolved

of solution,

and used

not more than 2 hours after preparation.
3*

Ehrlich's reagent!

aminobenzaldehyde
in 30 ml.

0.8 gm.

(Fisher Scientific Co.)

of absolute ethanol.

of £-dimethylwas dissolved

To this was added 30

ml. of concentrated hydrochloric acid.

The reagent was

used within 2 hours.

* Binder-free indomethacin (L-590,226-00A116) was
kindly supplied by F. A* Cutler, Ph.D. of Merck,
Sharp and Dohne Laboratories, F. 0. Box 2000,
Rahway, New Jersey 07065*
** 3inder-free sulfide metabolite of sulindac
(L-612,835“°OX25) was kindly supplied by Merck,
Sharp and Dohne Laboratories, above address.
*** Na arachidonate from Sigma Chemicals,
Missouri 63178.
Lot no. 18C-7580.

St. Louis,

.
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4.

Glucosamine standard solutions:

mg. of glucosamine EC1
solved in 100 ml.
until used

Fourteen

(Sigma Chemical Co.) were dis¬

of distilled water and kept refrigerated

(less than a week).

Procedure
Fresh articular cartilage was obtained from
adult dogs killed by intracardiac administration of
pentobarbital immediately before surgery.

The knees

were shaved and prepped with Betadine scrub and alcohol
and sterile technique was observed during the procedure.
Each knee joint was exposed employing an anteriorly
located vertical skin incision passing just medial to
the patella.

The joint was then entered with a hori¬

zontal incision through the anterior portion of the
capsule,

transecting both the medial and lateral collao

teral ligaments.

Finally,

the cruciate ligaments were

transected and the menisci were removed to expose the
articular surfaces.

A fresh scalpel blade

(#10)

was

then used to shave off pieces of articular cartilage.
Most of the cartilage used in the experiments came from
the femoral surfaces,

with additional amounts from the

tlblal and patellar surfaces.
2-3 mm. X 5 mm.

Most slices measured

and were of full thickness.

The slices

were immediately Introduced into the Incubating solutions
after pooling them in a Petri dish.
The flasks were incubated in an Sberbach
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shaker bath at 37°C ± 1 for 24 hours with moderate sha¬
king (60 - 90 strokes per minute).
period,

each flask was Inspected for cloudiness suggestive

of bacterial contamination.

Suspicious solutions were

sent for bacterial culture and,
carded.

At the end of this

if positive,

were dis¬

Each sample was defatted and partly dehydrated

by placing in 2 ml. of a 1:1 mixture of acetone and ethanol
for 24 hours.

The cartilage slices were recovered and

the solvent completely driven off by placing in an evac¬
uated oven at 60°C overnight.

Two to 3 mg« of the dry

cartilage was then weighed for the hexosamine assay.
The method for liberating the glucosamine was
derived from the work of Boas

(1953)*

Previous work done

in this laboratory had shown that the best results were
obtained (in terms of complete hydrolysis with minimal
decomposition)

by incubating the cartilage in 2 ml.

of

4.25 N hydrochloric acid in 10-ml. volumetric flasks
for 4 hours.

At the end of this period,

the solutions

were topped to the 10-ml. mark with distilled water and
filtered by gravity through Whatman no.

1

paper into a

second set of 10ml. volumetric flasks.
At this point,

blanks were prepared by pipet¬

ting into 10-ml. volumetric flasks 2 ml. of the same
4.25 N hydrochloric acid used in the hydrolysis and then
topping to the mark.
pipetting 0.5,

1.0,

The standards were prepared by
1.5 and 2.0 ml. of the glucosamine

HG1 standard solution into 10-ml. volumetric flasks,

add-

-
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ing 2 ml.

of 4.25 N hydrochloric acid and then topping to

the mark with distilled water.
however,

were not filtered.

The blanks and standards,

From this point on,

samples,

blanks and standards were treated in an identical fash¬
ion.
The method employed for the quantitative deter¬
mination of glucosamine was described by Rondle and
Morgan (1955)#

which was a modification of the original

method of Slson and Morgan (1933)*
A 3-mi* aliquot from each flask was pipetted
into a 10-ml. volumetric flask,

titrated to the phe-

nolphthalein end-point with 4 N NaOH and then backtitrated with 0.5 N HC1 until the pink returned to co¬
lorless.

Extreme care was necessary in this step since

the assay is sensitive to both salt concentration and
pH (3oas 1953).

Next,

1 ml.

of alkaline acetylacetone

was added to each flask and heated in a boiling water
bath for 30 minutes.

The flasks were allowed to cool

to room temperature.

About 2 ml. of absolute ethanol

were added,

followed by 1.0 ml.

of Ehrlich’s reagent,

in turn followed by sufficient ethanol to fill to the
10-ml. mark.

The flasks were warmed to 65 - 70°G in

a water bath for 15 minutes.
A Varian Series 634 spectrophotometer was
used to read the absorbance at 530 nm. at a slit width
of 1 nm. and a path length fo 1 cm.

All standards and

samples were read at least twice against a blank refer-
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ence and the average reading was used.
The standard curve was obtained using a lin¬
ear least squares plot.
On most runs,

the elapsed time between the

addition of acetylacetone and the spectrophotometric
determination was less than 6 hours.

Similarly,

the

elapsed time between the addition of Ehrlich's reagent
and final determination was less than 3 hours.
The data obtained was analyzed statistically
using the student t-test of significance.

35Results
The results of the experiments are represented
In Tables 1 through 3*

-All values obtained are expressed

in arbitrary units to facilitate comparison between
different experiments.

This is because,

icular assay method employed,

with the part¬

differences occur in the

absolute values obtained from one experiment to the
next,

although they are internally cons within each

experiment

(Rondle & Morgan 1955)»
Table 1 shows the effect of arachidonic acid

on the hexosamine content.

When the concentration

of the arachidonic acid in the incubating medium was
1 mcg/ml.,

no difference in the hexosamine content was

noted between that and the controls.

When the concen¬

tration of the arachidonic acid was increased to 10
mcg/ml.,

there was a significant

(?<0.01)

drop in the

hexosamine content from 100 to 72.6 arbitrary units.
Further increasing the concentration of arachidonic
acid to 100 mcg/ml. resulted in no change in the loss
of hexosamine.
The effects of indomethacin on the system are
shown in Table 2.
trarily to 100.

The control values are set arbi¬
As expected,

the presence of 10 mcg/ml.

of arachidonic acid caused a drop in the hexosamine
content,

although the statistical significance of the

results is not as good (P<0.10 for Dog A,
nificant for Dog B) .

results insig¬

Indomethacin alone did not cause

.
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a change in the concentration,
effect

per se on the cartilage.

showing that It has no
The results of having

both the indomethacin and arachidonlc acid in the medium
is slightly confusing.

In the case of Dog A,

the value

obtained is half-way between that of the control value
and that obtained with arachidonic acid alone.
B,

For Dog

the value indicates a fully protective effect from

the indomethacin.
of Dog A is small

Since the sample size in the case
(n=3),

one might expect it to be more

easily influenced by random errors and would be less
reliable.

The sample size in the case of Dog B is

bigger (n=6) and one would expect greater significance
in the result.

At any rate,

Dog A still shows some

protective effect rendered by the Indomethacin.
In Table 3.

the results of similar experiments,

but using the sulfide metabolite of sullndac,
Again,

are shown.

arachidonic acid causes loss of hexosamine.

The

values for Dog C are statistically insignifleant while
those for Dog D are

(P<0.05)«

The sulfide metabolite

of sullndac by itself causes no change in the hexos¬
amine content.

With both arachidonic acid and the sul¬

fide metabolite of sullndac together,
in the hexosamine content,

no change is noted

demonstrating the protective

effects of the sulfide metabolite of sullndac,
is the active form of the drug.

which

hexosamine content of articular cartilage
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Discussion
The foregoing experiments serve to demonstrate
the effect of arachidonic acid on cartilage degradation.
In all cases a drop in the amount of hexosamine is noted
in samples containing the arachidonic acid (but without
the prostaglandin synthetase inhibitors)

as compared to

controls which contained only lactated Ringer's solution
and alcohol or which contained indomethacin or sulindac.
Only low concentrations of arachidonic acid are necess¬
ary,

as shown by the observation that increasing the

concentration from 10 mcg/ml. to 100 mcg/ml. caused no
further increase in hexosamine loss.
Furthermore,

this not a direct effect of

the arachidonic acid itself since if that were true,
the indomethacin should not prevent the loss of hexo¬
samine induced by the arachidonic acid.
on the other hand,

One might argue,

that there may be a direct inter¬

action between the indomethacin and arachidonic acid.
The results are consistent with such a hypothesis as
well.

However,

there is little evidence in the literature

to support such a statement and there is much work to
support the hypothesis that the action of indomethacin
is by inhibition of prostaglandin synthesis
Ferreira & Vane 197^»

(Vane 1971,

etc.).

Since chondrocytes are the only cells present
in this system,
synthetase.

they must be the source of prostaglandin

This agrees well with the previously-
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mentioned work of Lippiello,

et al

(1977)

who demonstrat¬

ed that chondrocytes in cell culture were capable of
prostaglandin synthesis.

This system,

moreover,

has

the chondrocytes in a milieu which much better approx¬
imates the in vivo conditions.
Another advantage of this system is that there
is no interference from the enzyme systems from the
much more cellular synovium.

None of the work performed

on _in vivo systems can resolve the question as to whe¬
ther the prostaglandins came from the synovial or cart¬
ilage cell synthesizing systems.

This experiment shows

that the latter are capable of producing the prosta¬
glandins,

although the question as to whether these

prostaglandins or those originating from the synovium
are ultimately more important in cartilage degradation.
Certainly,

in conditions such as rheumatoid or septic

arthritis,

intense synovitis is seen and the large

amounts of prostaglandins detected in the joint fluid
probably originate from there.

However,

the earliest

osteoarthritic changes are detected in the articular
cartilage and not in the synovium and it seems reason¬
able to conclude that,

at least in the early stages,

the prostaglandins are derived from the chondrocytes.
Although,

in the experiments involving indo-

methacln and sulindac,
tically significant,
are quite clear.

the results are not as statis¬

the trends shown by the results

In all cases,

the effect of the arach-

.
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idonic acid In causing the loss of hexosaraine from the
articular cartilage cannot be demonstrated in the pre¬
sence of either indomethacin or the sulfide metabolite
of sulindac.
Dog A,

The only exception is perhaps the case of

where the value for hexosamine loss with both

Indomethacin and arachidonic acid present fell roughly
half-way between the values obtained for the controls
and for arachidonic acid alone.

However,

the problem

of the small sample size in that particular case has
been discussed in the foregoing section.
The results are thus consistent with the model
proposed above that the pathogenesis of osteoarthritis
occurs via a pathway of endogenously-produced prosta¬
glandins,

leading to the synthesis or activation of

proteases in the articular cartilage.
that sulindac,

It also shows

a recently released non-steroidal anti¬

inflammatory agent and a chemical congener of indome¬
thacin,

also works by inhibition of prostaglandin

synthesis.
One question which this experimental system
is unable to address is the identity of specific pro¬
staglandins synthesized.

There are at least 6 products

which may be formed from prostaglandin endoperoxide,
•5*

FGE'S>

PGF2K-

PGD,

PGI,

thromboxane.

toid synovial tissue in culture,
to be PGS2,

In rheuma¬

the main product appears

with some PGF2^ and PGB (Robinson

8c

Levine

'
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1974).

Also,

It Is well known that different prostag¬

landins can have very different and even opposing actions
(Vane 1971)*

Of note is the difference in actions be¬

tween PGS2 and PGF2X*

In rat knees following the injec¬

tion of cell-free extracts of Group A Streptococci,

a

rise in PGS2 was noted within an hour while a rise in
PGF2<* was noted only after 6 hours
Fulkerson,

(Floman,

et al 1977)*

et al (1978a) used PGS-]_ and PGS2 in the pre¬

sent system and obtained cartilage degradation in both
cases.

Some have proposed that PGE2 is an inflammatory

prostaglandin while PGF2^_ is an anti-inflammatory one
(Willoughby & Dieppe 1978).
hand,

Other workers,

on the other

have postulated a pro-inflammatory action for

PGF2<x (Weissmann,

et al 1978).

It would be useful as

a next step to actually identify which of the prostag¬
landins are released during incubation with arachidonic
acid and this would give Important information on the
more specific pathway of inflammation.
on,

From that point

more specific prostaglandin synthetase inhibitors

may be found which may have therapeutic advantages.
example,

For

the gastrointestinal side-effects of indome-

thacin have been attributed to depletion of PGSi and
PGE2 in the gastrointestinal mucosa (Vane 1971*

Robert

197^) which results in a breakdown of the mucus barrier.
If it turns out that prostaglandins other than PGE-j_ or
PGE2 are responsible for the osteoarthrltic changes and
specific inhibitors of these other prostaglandins can be
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found,

then the gastro-intestinal side effects of the

present agents can be avoided.
Another point which should be considered in
the light of these experiments is the actual effect
of the non-steroidal anti-inflammatory agents in clin¬
ical use.

Since the agents inhibited the degradation

of proteoglycans,

one could argue that,

in clinical

use,

it should retard the progression of osteoarthri¬

tis,

in addition to providing symptomatic relief.

There is,

however,

no data available as to whether

the non-steroidal anti-inflammatory agents actually
alter the course of the disease.

This is understand¬

able since the clinical course of osteoarthritis varies
tremendously and such long term follow-up studies would
be virtually impossible to undertake.
As to the symptomatic relief of osteoarthr¬
itis,

previous work has shown that FGT-j_ or PGE2 sensi¬

tized dogs to intra-articular injection of bradykinin
(Moncada,

et al 1975)*

The authors monitored blood

pressure as a measure of pain and showed that aspirin
or indomethacin prevented the effects of bradykinin
but not those of the prostaglandins.

Thus,

they con¬

cluded that local prostaglandin synthesis sensitizes
pain receptors to noxious stimuli.

It has also been

shown that incapacitation in dogs after intra-articu¬
lar injection of endotoxin was highly correlated with
the prostaglandin level in the synovial fluid

(Kerman
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& Moncada 1975) •

Thus,

prostaglandins mediate the symp¬

toms of pain and incapacitation in the disease.

It

would seem reasonable to conclude that the prostaglan¬
din synthetase inhibitors provide symptomatic relief
by interfering in this pathway.

There is no data at

present to show whether they have any effect of arti¬
cular cartilage preservation in osteoarthritis,

but

work on an analogous system has demonstrated such an
effect.

A study conducted on lateral dislocations of

the patella may shed some light on this question (Chrisman,

et al 1972,

Chrisman & Snook,

1968).

Patients were

treated with a course of aspirin after being seen for
the first episode of lateral dislocation of the patella.
When dislocation recurred,

surgical correction was rec¬

ommended and the amount of chondromalacia judged by the
system of Bentley

(1970) when surgery was performed.

In the untreated group,

21 out of 23 patients showed

evidence of chondromalacia of any degree while this was
true of only 3 of

16

knees in the aspirin-treated group.

Since chondromalacia is an early finding in osteoarthri¬
tis,

we have here an analogous situation which shows

that aspirin in fact helps retard cartilage degradation
in a clinical setting.

Possible sources of experimental error
Some of the values obtained in these experi¬
ments showed the trend quite clearly but the actual

.
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numbers were not always statistically significant.

It

would seem appropriate to discuss some of the possible
sources of error in the experimental system.
In the first place,

there is some variation

in the proteoglycan from animal to animal•(Maroudas
1975)*

The absolute amount of hexosamine cannot be

meaningfully compared between animals and therefore
arbitrary units have been employed.
given animal,
ent.

However,

for each

the results should be internally consist¬

This is not possible due to a second variation,

which is the variation in proteoglycan content as a
function of depth (Lipshitz,

et al 1976)

graphical location in the joint,

and topo¬

as discussed before.

Since the quantity of articular cartilage in each joint
is extremely limited and all the cartilage which could
be obtained had to be used,

there was little which

could be done to control for these two variables except
by cutting the cartilage into very small slices,

pool¬

ing the cartilage and randomizing the order by which
the incubation flasks were filled.
The next step where a source of error is likely
is the weighing of the dry cartilage.
were between 2 and 3 mg.
0.1 mg.,
mg.,

Most samples

Since the balance reads to

the accuracy of the weight

is at best +0.1

which when compared to the sample weight of 2 mg.,

is an error of at least 5 ,£•

A larger sample size

would lower this error but would give rise to the pro-

.
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blem of Incomplete hydrolysis.
It has been shown that hydrolysis of 0.5 mg.
of purified chondroitln-6-sulphate with 1 ml. of 4 N
hydrochloric acid under vaccuum at 110°C was complete
at 4 hours and shows a yield of greater than 90^ at
the end of 12 hours

(Johnson, _et al 1978).

The problem

we encountered was one of incomplete hydrolysis.
4 hours,

After

small flecks of black material were noted in

the hydrolysiate,
cartilage used.

which increased with the amount of
The chemical nature of these flecks

is unknown and therefore,

the possibility of their

containing an unknown amount of hexosamine cannot be
ruled out.

The error introduced in this step is in¬

determinate.

Carrying on the hydrolysis for a longer

period might circumvent this problem but we then run
into the possibility of decomposition of the hexosamine.
Finally,

Boas

(1953)

pointed out that many

naturally-occurring substances contained chromogens
other than hexosamines which would react to the rea¬
gents used to produce substances which absorbed at
530 nm. but with a different spectrum.
50

quantitative ion exchange column,

purify the hexosamines.

However,

Using a Dowex

he was able to

such a procedure was

not practical in this case because of the large numbers
of samples used and the small volume in each sample.
The error introduced here is again indeterminate.
can only be assumed that it was roughly the same in

It
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each case and the relative values,
portant ones in this experiment,

which were the im¬

were unaffected.
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Summary and Conclusions
Previous work has demonstrated that prosta¬
glandins can cause destruction of articular cartilage
and that this may be part of the pathogenetic pathway
of osteoarthritis.

This paper seeks to elucidate this

pathway by demonstrating the effect of arachidonlc acid
on articular cartilage.

We shall then attempt to de¬

monstrate that such an action can be Inhibited by indomethacln and sulindac.

The latter is a new non-steroidal

anti-inflammatory agent and we shall show that its action
is similar to that of indomethacin.
The results show that arachidonlc acid caused
a significant loss of hexosamines from articular cart¬
ilage.

The trends of the results show that this effect

can be inhibited by indomethacin or sulindac,

which do

so most likely by inhibition of prostaglandin synthesis.
Some of the possible sources of error in the
experimental system which may have contributed to the
lack of statistical significance in some of the numbers
are discussed.

Repeating the experiments using larger

sample sizes may give more statistically significant
results
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